It’s mainly the age and the source, which – in the case of embryonic stem cells – is embryonic tissue. Although embryonic stem cells have higher biological potency, their use is not only ethically questionable but also associated with a higher risk of malignancies (cancer). Therefore the patient will profit more from the use of his own stem cells, which can be expected to remain biologically highly potent up to high age.